EP3653221

COMPUGEN LTD.
Application Number
EP19214231A
Filing Date
Feb 19, 2016
Status
Granted And Under Opposition
Jul 1, 2022
Grant Date
Aug 3, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3653221B1 was granted on Aug 3, 2022 by Compugen Ltd. The patent is currently Granted And Under Opposition.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEDMay 2, 2023ADMISSIBLE
ZACCO DENMARK A/SMay 2, 2023ADMISSIBLE

The table below shows the patents of Compugen Ltd. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3259597Pvrig Polypeptides And Methods Of TreatmentApr 6, 20221
EP3258951Anti-Pvrig Antibodies And Methods Of UseJan 29, 20202